A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
Recruiting · NCT07185347 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene | Diplopia, Dyskinesias, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, atactic disorder, non-human animal, eye disorder, nervous system disorder, vision disorder | Recruiting | Phase 3 | 2025-12-10 | NCT07185347 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Genetics Department, CHU de Bordeaux | Bordeaux | France | 1 |
| Genetics Department, CHU de Rouen | Rouen | France | 1 |
| Genetics Department, Pitié-Salpêtrière University Hospital | Paris | France | 1 |
| Neurology and Gentics Department, CHU de Dijon | Dijon | France | 1 |
| Neurology Department, CHRU de Strasbourg | Strasbourg | France | 1 |
| Neurology Department, CHU d'Angers | Angers | France | 1 |
| Neurology Department, CHU de Toulouse | Toulouse | France | 1 |
| Neurology Department, Gui De Chauliac Hospital | Montpellier | France | 1 |
| Neurology Department, Hôpital Pierre Wertheimer Hospital | Lyon | France | 1 |